A biopharmaceutical company focused on the discovery, development and commercialization of novel drugs by applying proprietary technology, scientific expertise and unique capabilities for targeting the liver and liver pathways.
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about MBRX.DL.
Recs
vkrish98
(53.56)
Submitted: 7/19/2007 1:24:24 PM :
Start Price:
$3.01
NASDAQ:MBRX.DL Score:
-279.42
I have no idea when I picked this. Oh well!!
Find the members with the highest scoring picks in MBRX.DL.
SteadySaber (84.97) Score: +299.32
The Score Leader is the player with the highest score across all their picks in MBRX.DL.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SteadySaber | 84.97 | 8/1/2007 |
|
5Y | $3.17 | -90.22% | +209.09% | +299.32 | 0 Comment | |
| lonewolf39 | 84.42 | 7/17/2007 |
|
1Y | $2.99 | -89.63% | +189.31% | +278.94 | 0 Comment | |
| spikenail | < 20 | 7/17/2007 |
|
NS | $2.99 | -89.63% | +188.64% | -278.27 | 0 Comment | |
| vkrish98 | 53.56 | 7/17/2007 |
|
3M | $3.01 | -89.70% | +189.72% | -279.42 | 1 Comment | |
| jeffbenes | 65.84 | 2/12/2007 |
|
5Y | $6.98 | -95.56% | +214.34% | -309.90 | 0 Comment | |
| hibetals | 94.75 | 2/28/2007 |
|
NS | $8.02 | -96.13% | +219.93% | -316.06 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
